21st Century Cures to hold personalized medicine roundtable

The House Energy and Commerce Committee's 21st Century Cures initiative will discuss genomic sequencing and diagnostic testing during a roundtable discussion on personalized medicine on July 23. The committee will explore how regulation of these areas affects innovative product development and delivery.

Participants include Jeffrey Shuren, director of FDA's Center for Devices and Radiological Health (CDRH); Richard Moscicki, deputy director for science operations of the agency's Center for Drug Evaluation and Research (CDER); Sean Bohen, SVP of early development at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY); and Patrick Groody, senior director of integrated business planning at Abbott Laboratories (NYSE:ABT). ...